HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.

Abstract
The congenital disorder 22q11.2 deletion syndrome (22qDS), characterized by a hemizygous deletion of 1.5-3 Mb on chromosome 22 at locus 11.2, is the most common microdeletion disorder (estimated prevalence of 1 in 4000) and the second risk factor for schizophrenia. Nine of ∼30 genes involved in 22qDS have the potential of disrupting mitochondrial metabolism (COMT, UFD1L, DGCR8, MRPL40, PRODH, SLC25A1, TXNRD2, T10, and ZDHHC8). Deficits in bioenergetics during early postnatal brain development could set the basis for a disrupted neuronal metabolism or synaptic signaling, partly explaining the higher incidence in developmental and behavioral deficits in these individuals. Here, we investigated whether mitochondrial outcomes and metabolites from 22qDS children segregated with the altered dosage of one or several of these mitochondrial genes contributing to 22qDS etiology and/or morbidity. Plasma metabolomics, lymphocytic mitochondrial outcomes, and epigenetics (histone H3 Lys-4 trimethylation and 5-methylcytosine) were evaluated in samples from 11 22qDS children and 13 age- and sex-matched neurotypically developing controls. Metabolite differences between 22qDS children and controls reflected a shift from oxidative phosphorylation to glycolysis (higher lactate/pyruvate ratios) accompanied by an increase in reductive carboxylation of α-ketoglutarate (increased concentrations of 2-hydroxyglutaric acid, cholesterol, and fatty acids). Altered metabolism in 22qDS reflected a critical role for the haploinsufficiency of the mitochondrial citrate transporter SLC25A1, further enhanced by HIF-1α, MYC, and metabolite controls. This comprehensive profiling served to clarify the biochemistry of this disease underlying its broad, complex phenotype.
AuthorsEleonora Napoli, Flora Tassone, Sarah Wong, Kathleen Angkustsiri, Tony J Simon, Gyu Song, Cecilia Giulivi
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 290 Issue 38 Pg. 23240-53 (Sep 18 2015) ISSN: 1083-351X [Electronic] United States
PMID26221035 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.
Chemical References
  • Anion Transport Proteins
  • Carrier Proteins
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • MYC protein, human
  • Mitochondrial Proteins
  • Organic Anion Transporters
  • Proto-Oncogene Proteins c-myc
  • Slc25a1 protein, human
  • citrate-binding transport protein
Topics
  • Abnormalities, Multiple (genetics, metabolism, pathology)
  • Adolescent
  • Anion Transport Proteins (genetics, metabolism)
  • Carrier Proteins (genetics, metabolism)
  • Child
  • Chromosome Deletion
  • Chromosomes, Human, Pair 22 (genetics, metabolism)
  • DiGeorge Syndrome (genetics, metabolism, pathology)
  • Female
  • Glycolysis (genetics)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics, metabolism)
  • Lymphocytes (metabolism, pathology)
  • Male
  • Mitochondria (genetics, metabolism, pathology)
  • Mitochondrial Proteins (genetics, metabolism)
  • Organic Anion Transporters
  • Oxidative Phosphorylation
  • Proto-Oncogene Proteins c-myc (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: